EU Panel Backs Dapagliflozin for Some With Type 1 Diabetes EU Panel Backs Dapagliflozin for Some With Type 1 Diabetes

If approved, it would be the first oral add-on to insulin worldwide, but could only be used in patients in whom risk of diabetic ketoacidosis can be properly mitigated.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news